The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems.
Walczak
H
H
Tumorimmunology Program, German Cancer Research Center, Heidelberg, D-69120, Germany.
Krammer
P H
PH
D000818:Animals; D017209:Apoptosis / Q000502:physiology*; D051017:Apoptosis Regulatory Proteins; D053222:Fas Ligand Protein; D006801:Humans; D008099:Liver / Q000502:physiology; D008562:Membrane Glycoproteins / Q000502:physiology*; D013601:T-Lymphocytes / Q000502:physiology; D053221:TNF-Related Apoptosis-Inducing Ligand; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology*; D019014:fas Receptor / Q000502:physiology*
D051017:Apoptosis Regulatory Proteins; C505661:FASLG protein, human; D053222:Fas Ligand Protein; D008562:Membrane Glycoproteins; D053221:TNF-Related Apoptosis-Inducing Ligand; C505653:TNFSF10 protein, human; D014409:Tumor Necrosis Factor-alpha; D019014:fas Receptor